Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 11, 2025 03:00 ET | Source: inbiome

Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals

www.inbiome.com Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID...
January 23, 2025 07:30 ET | Source: FACT.MR

Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion by 2034 at a CAGR Of 6.3% | Fact.MR Report

Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of...
December 26, 2024 04:45 ET | Source: Research and Markets

Antibiotic Resistance Therapeutics Market Research Report 2025-2029 - Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides"...
October 15, 2024 10:31 ET | Source: Research and Markets

Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies

Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
September 26, 2024 04:03 ET | Source: inbiome

Inbiome Receives FDA Breakthrough Device Designation for Revolutionary Molecular Culture ID Technology, Transforming Bacterial Diagnostics

www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
September 02, 2024 05:59 ET | Source: Research and Markets

Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%

Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "Impetigo Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Impetigo Drugs was...
July 25, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Global Antibiotic Resistance Market to Exhibit Growth at a CAGR of ~6% by 2030| DelveInsight

New York, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Global Antibiotic Resistance Market to Exhibit Growth at a CAGR of ~6% by 2030| DelveInsight The rising challenge of antibiotic-resistant...
May 27, 2024 03:01 ET | Source: Research and Markets

Antibiotic Resistance Markets Therapeutics, by Pathogen and Therapy Type to 2027: Search for Alternatives to Antibiotics Creates New Global Goldrush

Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization....
January 25, 2024 04:19 ET | Source: Research and Markets

Glycopeptide Antibiotics Global Market Report 2024: Forecast to Reach $5.02 Billion by 2028 - Long-term Forecast to 2028 and 2033

Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
January 22, 2024 05:18 ET | Source: Research and Markets

Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024: A USD 4.07 Billion Market by 2034, with Novel Antibiotics and Combination Therapies Emerging

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas...

Next Page keyboard_arrow_right